Malignant Gestational Trophoblastic Neoplasia

 MALIGNANT GESTATIONAL TROPHOBLASTIC NEOPLASIA

 

Postmolar or persistent GTD is only one of the many forms of malignant GTD. Although invasive moles are his-tologically identical to antecedent molar pregnancies while invading the myometrium, choriocarcinomas are a malig-nant transformation of trophoblastic tissue. Instead of hydropic chorionic villi, the tumor has a red granular appearance on cut suction and consists of intermingled syncytiotrophoblastic and cytotrophoblastic elements with many abnormal cellular forms. Clinically, choriocarcino-mas are characterized by rapid myometrial and uterine-vessel invasion and systemic metastases resulting from hematogenous embolization. Lung, vagina, central ner-vous system, kidney, and liver are common metastatic loca-tions. Choriocarcinoma may follow a molar pregnancy, normal-term pregnancy, abortion, or ectopic pregnancy. In the United States, choriocarcinoma is associated with approximately 1 in 150,000 pregnancies, 1 in 15,000 abor-tions, 1 in 5000 ectopic pregnancies, and 1 in 40 molar pregnancies.

 

Early identification and treatment are important. Abnormal bleeding for more than 6 weeks after any pregnancy should be evaluated with hCG testing to exclude a new pregnancy or GTD. Failure of quantitative hCG levels to regress aftertreatment of a molar pregnancy suggests that further treat-ment is needed. Identified metastatic sites should not be biopsied to avoid bleeding complications. Most GTN,including malignant forms, are highly sensitive to chemotherapy and often results in a cure, allowing for future reproduction.

 

Nonmetastatic persistent GTN is completely treated by single-agent chemotherapy. Single-agent chemotherapy iseither methotrexate or actinomycin D. The prognosis for metastatic GTN is more complex, divided into good and poor prognostic categories (Table 41-2). The World Health Organization (WHO) has developed a prognostic scoring system for GTN that includes a number of epi-demiologic and laboratory findings; this system was later combined into the International Federation of Gynecology and Obstetrics (FIGO) staging system (Table 41-3). A FIGOscore of 7 or above classifies metastatic GTN as high-risk, requir-ing multi-agent chemotherapy. The combination chemother-apeutic regimen with the highest success rates is: etoposide,methotrexate, actinomycin D, cyclophosphamide, andOncovin (vincristine)) [EMACO]. Adjunctive radiother-apy is sometimes performed with patients who have brain or liver metastasis. Surgery may be necessary to control hem-orrhage, remove chemotherapy-resistant disease, and treat other complications to stabilize high-risk patients during intensive chemotherapy. Cure rates for non-metastatic and good-prognosis metastatic disease approach 100%. Cute rates for poor-prognosis metastatic disease are 80% to 90%.

 

Comments

Post a Comment

Popular posts from this blog

The Postpartum Visit

  THE POSTPARTUM VISIT   At the time of the first postpartum visit, inquiries should be made into the following: status of breastfeeding, re-turn of menstruation, resumption of coital activity, use of contraception, interaction of the newborn with the fam-ily, and resumption of other physical activities such as return to work. Observation about and appropriate ques-tions concerning sadness and depression, anxiety, the par-ents’ concerns about infant care, and the relationship of mother and her partner are also part of the first postpar-tum visit. Involutional changes will have occurred in most instances. Inflammatory changes because of the healing of the cervix may result in minor atypia on a Pap smear performed at this time. Unless there is a history of signifi-cant cervical dysplasia, repeating the Pap smear in 3 months is appropriate.
Read more

Clinical Findings of Tubal Ectopic Pregnancy

  CLINICAL FINDINGS   Abdominal and pelvic findings are notoriously scant in many women before tubal rupture. Prior to rupture, the di-agnosis of an ectopic pregnancy is primarily based on labo-ratory and ultrasound findings. With rupture, however, nearly three-fourths of women will have marked tender-ness on both abdominal and pelvic examination, and pain is aggravated with cervical manipulation. A pelvic mass, in-cluding fullness posterolateral to the uterus, can be palpated in about 20% of women. Initially, the ectopic pregnancy may feel soft and elastic, whereas extensive hemorrhage produces a firmer consistency. Many times, discomfort pre-cludes palpation of the mass. Avoidance of pelvic examina-tions may actually help avert iatrogenic rupture.   Fever is not expected, although a mild elevation in temperature in response to intraperitoneal blood may occur. A temperature of 38 ° C may suggest an infectious cause to a patient’s symptoms. Abdominal distension and tender...
Read more

Anxiety, Depression, and the Postpartum Period

Image
  ANXIETY, DEPRESSION, AND THE POSTPARTUM PERIOD   Although pregnancy and childbirth are usually joyous times, depression to some degree is actually common in the postpartum period. There is a wide spectrum of response to pregnancy and delivery, ranging from mild postpartum blues to postpartum depression (Table 11.2). Approximately 70% to 80% of women report feeling sad, anxious, or angry beginning 2–4 days after birth. These  postpartumblues  may come and go throughout the day, are usuallymild, and abate within 1 to 2 weeks. Supportive care and reassurance are helpful in ensuring that symptoms are self-limited. Approximately 10% to 15% of new mothers ex-perience  postpartum depression (PPD),  which is a more serious disorder and usually requires medication and counseling.  PPD differs from postpartum blues in the sever-ity and duration of symptoms.  Women with PPD have pro-nounced feelings of sadness, anxiety, and despair that interfere with acti...
Read more